BREAKING: NAFDAC Approves AstraZeneca COVID-19 Vaccine For Use In Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the Oxford/AstraZeneca COVID-19 vaccine for use in Nigeria.
The Director-General of NAFDAC, Dr. Mojisola Adeyeye, disclosed this on Thursday.
The vaccine was recently approved by the WHO for emergency use.
Adeyeye said NAFDAC got the dossier of the vaccine a week ago, and its safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine.